CD5 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Inuvo Inc

Watchlist Manager

Watchlist

Price: 0.525 EUR -7.89% Market Closed

Market Cap: €7.7m

	Inuvo Inc F:CD5	US
C	Chugai Pharmaceutical Co Ltd XMUN:CUP	JP
C	Chugai Pharmaceutical Co Ltd F:CUP	JP
A	Arrail Group Ltd F:I1D	CN
C	Chugai Pharmaceutical Co Ltd DUS:CUP	JP

Profitability Summary

Inuvo Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

63%

Strong 3Y Average Gross Margin

80%

Declining Gross Margin

72% > 63%

Negative Operating Margin

-19%

Negative 3Y Average Operating Margin

-10%

Operating Margin is Increasing

-23% > -19%

Negative Net Margin

-9%

Negative 3Y Average Net Margin

-8%

Net Margin is Increasing

-23% > -9%

Negative Free Cash Flow Margin

-7%

Negative 3Y Average Free Cash Flow Margin

-4%

Free Cash Flow Margin is Increasing

-12% > -7%

Negative ROE

-44%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-38%

ROIC is Increasing

-57% > -49%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.